ATA-100 (Formerly GNT0006) Gene Therapy Trial in Patients With LGMDR9
ATA-100 (Formerly GNT0006) Gene Therapy Trial in Patients With LGMDR9
Active, not recruiting · NCT05224505 · Registry updated 2025-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ATA-100 (Formerly GNT0006) Gene Therapy Trial in Patients With LGMDR9 | autosomal recessive limb-girdle muscular dystrophy type 2I | Active, not recruiting | Phase 1 | 2025-10-06 | NCT05224505 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Atamyo Therapeutics | 2 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Institute of Myology Pitié-Salpêtrière Hospital 47 Bd de l'Hôpital | Paris | France | 1 |
| Rigshospitalet, University of Copenhagen Blegdamsvej 9 | Copenhagen | Denmark | 1 |
| Royal Victoria Infirmary Queen Victoria Road Level 6 Leazes Wing | Newcastle upon Tyne | United Kingdom | 1 |